Research Overview: Stanozolol 10mg Ergo
Stanozolol 10mg Ergo is a synthetic anabolic androgenic steroid derived from dihydrotestosterone, extensively utilised in laboratory research to investigate anabolic mechanisms and cellular protein synthesis pathways. This compound exhibits unique structural modifications that distinguish it from its parent hormone, making it particularly valuable for researchers studying steroid receptor interactions and tissue-selective anabolic effects. The Ergo formulation provides consistent dosing parameters essential for controlled laboratory investigations. Researchers at Stroid UK Shop frequently examine this compound’s molecular interactions with androgen receptors and its influence on nitrogen retention in cellular models. The compound’s methylated structure allows for detailed analysis of hepatic metabolism pathways and protein synthesis modulation. Scientific studies have investigated stanozolol’s effects on collagen synthesis, bone density markers, and muscle fiber composition in various research models. The 10mg concentration provides optimal parameters for dose-response studies and comparative analysis with other stanozolol research preparations available for laboratory investigation.
Laboratory Research Applications
Research applications for Stanozolol 10mg Ergo encompass multiple areas of scientific investigation, including anabolic pathway analysis, receptor binding studies, and metabolic research. Cellular studies examine the compound’s interaction with androgen receptors and subsequent gene expression modifications. Researchers investigate stanozolol’s influence on protein synthesis markers, nitrogen balance parameters, and collagen production pathways. The compound serves as a valuable tool for studying steroid metabolism, hepatic enzyme induction, and clearance mechanisms in laboratory settings. Comparative studies often examine stanozolol alongside selective androgen receptor modulators to understand tissue-selective anabolic effects. Additional research focuses on the compound’s interaction with growth factors, IGF-1 pathways, and muscle fiber protein composition. Studies also investigate stanozolol’s effects on lipid profiles, cardiovascular markers, and bone density parameters. Research into the compound’s influence on peptide hormone interactions provides insights into complex anabolic signaling cascades and metabolic regulation mechanisms.
Technical Specifications
| Parameter | Specification |
|---|---|
| Active Compound | Stanozolol |
| Concentration | 10mg per unit |
| Chemical Formula | C21H32N2O |
| Molecular Weight | 328.49 g/mol |
| CAS Number | 10418-03-8 |
| Storage Temperature | Room temperature |
| Stability Period | 36 months sealed |
| Research Grade | Laboratory standard |
Research Compliance Information
Stanozolol 10mg Ergo is manufactured exclusively for in-vitro research applications and laboratory investigation purposes. This product is not intended for human consumption, therapeutic use, or any application outside controlled laboratory environments. Researchers must maintain appropriate laboratory protocols, safety procedures, and regulatory compliance when conducting studies with this compound. All research must be performed by qualified personnel in approved laboratory facilities with proper ventilation and safety equipment.
